<DOC>
	<DOCNO>NCT01015521</DOCNO>
	<brief_summary>This phase II study ass efficacy Aminoflavone prodrug triple negative ER+ breast cancer .</brief_summary>
	<brief_title>Efficacy Study Aminoflavone Prodrug Treat Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>ER+ TN Breast Cancer Progression aromatase inhibitor ER+ Prior treatment taxane TN 18 year old Adequate organ function Measurable lesion symptomatic pulmonary disease brain metastasis pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>breast cancer</keyword>
</DOC>